These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 38682749)
41. Retraction: Wang Y, Yue D. CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway. Cancer Med; 2024 Apr; 13(7):e7138. PubMed ID: 38546000 [TBL] [Abstract][Full Text] [Related]
42. RETRACTION: Zebularine Enhances Apoptosis of Human Osteosarcoma Cells by Suppressing Methylation of ARHI. Cancer Sci; 2024 Dec; 115(12):4080. PubMed ID: 39282753 [TBL] [Abstract][Full Text] [Related]
44. Retraction: Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu H, Ye Z, Li LC (2014) Up-regulation of p21 FEBS Lett; 2024 Jun; 598(11):1449. PubMed ID: 38747074 [TBL] [Abstract][Full Text] [Related]
45. Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1. Asia Pac J Clin Oncol; 2023 Dec; 19(6):762. PubMed ID: 37888963 [TBL] [Abstract][Full Text] [Related]
46. RETRACTION: MeCP2 Drives Hepatocellular Carcinoma Progression Via Enforcing HOXD3 Promoter Methylation and Expression Through the HB-EGF/EGFR Pathway. Mol Oncol; 2024 Aug; 18(8):2061. PubMed ID: 38837853 [TBL] [Abstract][Full Text] [Related]
53. RETRACTION: MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo. Cancer Med; 2024 Oct; 13(19):e70300. PubMed ID: 39387476 [TBL] [Abstract][Full Text] [Related]